{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:31:34Z","timestamp":1793395894008,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":291,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.toxrep.2022.10.011","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T01:20:03Z","timestamp":1666488003000},"page":"1950-1952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reversible cefazolin-induced status epilepticus in a peritoneal dialysis patient"],"prefix":"10.1016","volume":"9","author":[{"given":"Chien-Chou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Jie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2022.10.011_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/039139889401700501","article-title":"Seizures and renal failures","volume":"17","author":"Bergen","year":"1994","journal-title":"Int J. Artif. Organs"},{"key":"10.1016\/j.toxrep.2022.10.011_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2018.03.021","article-title":"Seizures, antiepileptic drugs, and CKD","volume":"73","author":"T\u00edtoff","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.toxrep.2022.10.011_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.toxrep.2022.10.011_bib4","first-page":"114","article-title":"Aciclovir and valaciclovir neurotoxicity in patients with renal failure","volume":"32","author":"Ruiz-Roso","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.toxrep.2022.10.011_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nefro.2020.03.004","article-title":"Prevalence and risk factors of baclofen neurotoxicity in patients with severely impaired renal function","volume":"40","author":"Cheong","year":"2020","journal-title":"Nefrologia"},{"key":"10.1016\/j.toxrep.2022.10.011_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0736-4679(01)00474-7","article-title":"Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department","volume":"22","author":"Pesola","year":"2002","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.toxrep.2022.10.011_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.toxrep.2022.10.011_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.V1161117","article-title":"Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients","volume":"11","author":"Low","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.toxrep.2022.10.011_bib9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/clinids\/13.4.772","article-title":"Cefazolin-induced encephalopathy in uremic patients","volume":"13","author":"Ortiz","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.toxrep.2022.10.011_bib10","first-page":"72","article-title":"Cefazolin-induced encephalopathy in a uraemic patient","volume":"45","author":"Josse","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.toxrep.2022.10.011_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French pharmacovigilance database","volume":"398","author":"Lacroix","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxrep.2022.10.011_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxrep.2022.10.011_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1528-1157.1983.tb04913.x","article-title":"Epileptogenic activity of cephalosporins in rats and their structure-activity relationship","volume":"24","author":"Kamei","year":"1983","journal-title":"Epilepsia"},{"key":"10.1016\/j.toxrep.2022.10.011_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0896860819893820","article-title":"Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis","volume":"40","author":"Triyawatanyu","year":"2020","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.toxrep.2022.10.011_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3747\/pdi.2015.00008","article-title":"Pharmacokinetics of intraperitoneal cefalothin and cefazolin in patients being treated for peritoneal dialysis-associated peritonitis","volume":"36","author":"Roberts","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.toxrep.2022.10.011_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijantimicag.2003.11.004","article-title":"Mechanisms of antibiotic neurotoxicity in renal failure","volume":"23","author":"Chow","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.toxrep.2022.10.011_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cpt1976196825","article-title":"Pharmacokinetics and hemodialyzability of cefazolin in uremic patients","volume":"19","author":"Craig","year":"1976","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022002074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022002074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:52:51Z","timestamp":1793393571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750022002074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":17,"alternative-id":["S2214750022002074"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.10.011","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible cefazolin-induced status epilepticus in a peritoneal dialysis patient","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}